Synergy of piracetam and aminalon in the cerebroprotective effect of olatropyl

Journal Title: Медичні перспективи - Year 2018, Vol 23, Issue 3

Abstract

Optimization of pharmacotherapy of neurological and psychosomatic diseases led to the creation of com¬bined medicines containing two or more components with different mechanisms of action, differently affecting the pathogenesis and clinical manifestations of specific forms of pathology. Combined drugs that help normalize the central regulatory mechanisms of the development of somatic pathology, improve brain metabolism and hemodynamics, stabilize the cortical-subcortical relationships, the disorders of which lie at the base of many forms of neurological and psychosomatic pathology have been particularly popular in recent years. In this article we propose options for opti¬mizing nootropic therapy with olatropyl, which is a combination of two "true" nootropics - gamma-aminobutyric acid (aminalone) and piracetam in one drug form. Such a combination allows one-stage implementation of a complex of multifaceted and diverse effects on the central nervous system characteristic of both piracetam and aminalone, but achieved through fundamentally different mechanisms of action of these agents. The mechanism of action of olatropil demonstrates the pronounced synergism of the monocomponents of the preparation. This combination allows to reduce the therapeutic dosages of each of the active substances by 2 times, which, in turn, leads to a decrease in the incidence and severity of possible side effects; leveling the exciting effect of piracetam and providing higher safety and efficacy. The drug is an effective tool for the therapy of various forms of cerebrovascular pathology, improving cognitive functions, mental activity, psychoemotional status, autonomic functions, favorably affecting the quality of life of patients. The uniqueness of the mechanism of action of olatropil, consisting in the occurrence of the fact of pharmacodynamic synergy in the combined use of piracetam and aminalone in a single dosage form, contributes to the enhancement of positive pharmacological effects and the leveling of a number of negative elements of pharmacodynamics of preparation constituents.

Authors and Affiliations

V. I. Mamchur, S. N. Dronov

Keywords

Related Articles

The morphological and morphometric study of tissues of dentoalveolar system in children with impaired course of the antenatal period

Anomalies and deformation of dental system in children and adolescents contribute not only to the deterioration of dental health, bat quite often this is the cause of a wide range of somatic pathology. The aim of our stu...

Features of teaching thermal injury course for the third-year students at the general surgery department

In the article, on the basis of methodological recom¬mendations on the introduction of the European credit transfer system and its documents, current issues of optimizing the educational process, the effectiveness of mas...

Molecular genetic and cytogenetic determinants of primary resistance or loss of the response to treatment with tyrosine kinase inhibitors in patients with chronic myeloid leukemia

Aim of this study was to analyze molecular genetic and cytogenetic reasons for disease resistance to tyrosine kinase inhibitors (TKI) imatinib (IM) and nilotinib (NI) in patients with chronic myeloid leukemia (CML). Mate...

Neutrophil-to-lymphocyte ratio in predicting prognosis and course of community community-acquired pneumonia in hospitalized patients

Currently, a marker which could be used both to assess the severity of community acquired pneumonia (CAP) and determine the risk of complications is being searched. According to some authors, Neutrophil-to-Lymphocyte Rat...

Диагностика инсиденталом надпочечниковых желез

Діагностика інсиденталом надниркових залоз. Кутовой А.Б., Жмуренко Э.В., Куник Л.В. У ро­боті проаналізовані результати обстеження і лікування 91 пацієнта з інсиденталомами наднирників. За результатами морфологічного дос...

Download PDF file
  • EP ID EP439167
  • DOI 10.26641/2307-0404.2018.3.147945
  • Views 103
  • Downloads 0

How To Cite

V. I. Mamchur, S. N. Dronov (2018). Synergy of piracetam and aminalon in the cerebroprotective effect of olatropyl. Медичні перспективи, 23(3), 4-12. https://europub.co.uk/articles/-A-439167